A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 118.25
GOOG 807.67
MSFT 60.99
FB 132.29
BAC 16.72

Recently Added

FDS 153.04
DGX 83.17
AMZ 0.00
EAT 49.49
MDM 5.30

Gaining Speed

FDS 153.04
AMZ 0.00
DGX 83.17
LOW 68.47
AOS 46.74

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More

Get Alerted When News Hits On This Stock - FREE!